Back

The determinants of functional significance of coronary bifurcation lesions and its implications on clinical follow up to 48 months (insights from FIESTA registry)

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: PCI outcomes: focus on long term follow-up Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Kiril Karamfiloff

University Hospital Alexandrovska, Sofia (Bulgaria)

6 More presentations in this session

Presentation thumbnail
Impact of Dual Antiplatelet Therapy duration on clinical outcome after stent implantation for coronary bifurcation lesions: results from the Euro Bifurcation Club - P2BiTO - registry
Doctor L. Di Serafino (Naples, IT)
Abstract Slides
Presentation thumbnail
Impact of successful coronary intervention for chronic total occlusion on long-term clinical outcome of patients with impaired and preserved left ventricular ejection fraction
Doctor H. Tanaka (Kurashiki, JP)
Abstract Slides
Presentation thumbnail
Impact of treatment strategies on long-term outcome of CTO patients
Doctor C. Roth (Vienna, AT)
Presentation thumbnail
Impact of coronary artery calcification on long-term outcomes after implantation of first and second-generation drug-eluting stents: a patient-level analysis of 18 randomized trials
Doctor P. Guedeney (Paris, FR)
Abstract Slides
Presentation thumbnail
Impact of strut thickness, of number of crown and connectors on clinical outcomes on patients treated with second generation DES.
Doctor P. Gatti (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
PCI outcomes: focus on long term follow-up

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Presentation
Association of PCI with outcomes in stable coronary artery disease
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources